National Institute of Neurological Disorders and Stroke, Interagency Pain Research Coordinating Committee Call for Committee Membership Nominations, 41993-41994 [2019-17631]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 159 / Friday, August 16, 2019 / Notices
Dated: August 13, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
[FR Doc. 2019–17663 Filed 8–15–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKBBV9HB2PROD with NOTICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
240: Innovative Research in Cancer
Nanotechnology.
Date: September 17, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites—Chevy Chase
Pavillion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–17606 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:10 Aug 15, 2019
Jkt 247001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel Rare Disease Applications.
Date: September 10, 2019.
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm 1078, Bethesda, MD 20892, 301–
594–7319, khanr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–17609 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RM19–001:
SPARC/HEAL Mapping of Pain-Related
Visceral Organ Neural Circuitry.
Date: August 23, 2019.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Robert C Elliott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–17608 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke, Interagency Pain
Research Coordinating Committee Call
for Committee Membership
Nominations
AGENCY:
National Institutes of Health,
HHS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
National Institutes of Health
SUMMARY:
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
41993
Notice.
The Department of Health and
Human Services (HHS) (Department)
has created the Interagency Pain
Research Coordinating Committee
(IPRCC) and is seeking nominations for
this committee.
DATES: Nominations are due by COB
September 23, 2019.
ADDRESSES: Nominations must be
submitted through the webform on the
IPRCC website: https://iprcc.nih.gov/
About/Membership-AgencyRepresentation/Nomination-Form.
FOR FURTHER INFORMATION CONTACT:
Linda Porter, porterl@ninds.nih.gov or
301–451–4460.
E:\FR\FM\16AUN1.SGM
16AUN1
41994
Federal Register / Vol. 84, No. 159 / Friday, August 16, 2019 / Notices
As
specified in Public Law 111–148
(‘‘Patient Protection and Affordable Care
Act’’) the Committee will:
(A) Develop a summary of advances
in pain care research supported or
conducted by the Federal agencies
relevant to the diagnosis, prevention,
and treatment of pain and diseases and
disorders associated with pain;
(B) identify critical gaps in basic and
clinical research on the symptoms and
causes of pain;
(C) make recommendations to ensure
that the activities of the National
Institutes of Health and other Federal
agencies are free of unnecessary
duplication of effort;
(D) make recommendations on how
best to disseminate information on pain
care; and (e) make recommendations on
how to expand partnerships between
public entities and private entities to
expand collaborative, cross-cutting
research.
Membership on the committee will
include six (6) non-Federal members
from among scientists, physicians, and
other health professionals and six (6)
non-Federal members of the general
public who are representatives of
leading research, advocacy, and service
organizations for individuals with painrelated conditions. Members will serve
overlapping three year terms. It is
anticipated that the committee will meet
at least once a year.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of diverse ethnic and racial groups and
people with disabilities are represented
on HHS Federal advisory committees,
and the Department therefore,
encourages nominations of qualified
candidates from these groups. The
Department also encourages geographic
diversity in the composition of the
Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
The Department is soliciting
nominations for 1 non-federal member
from among scientists, physicians, and
other health professionals and for 3 nonfederal members of the general public
who represent a leading research,
advocacy, or service organization for
people with pain-related conditions.
These candidates will be considered to
fill positions opened through
completion of current member terms.
Nominations are due by COB September
khammond on DSKBBV9HB2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
16:10 Aug 15, 2019
Jkt 247001
23, 2019, using the IPRCC nomination
webform: https://iprcc.nih.gov/About/
Membership-Agency-Representation/
Nomination-Form.
Dated: August 9, 2019.
Walter J. Koroshetz,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2019–17631 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2019–0002; Internal
Agency Docket No. FEMA–B–1953]
Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
Management Agency (FEMA) for each
community, is appropriate because of
new scientific or technical data. The
FIRM, and where applicable, portions of
the FIS report, have been revised to
reflect these flood hazard
determinations through issuance of a
Letter of Map Revision (LOMR), in
accordance with Federal Regulations.
The LOMR will be used by insurance
agents and others to calculate
appropriate flood insurance premium
rates for new buildings and the contents
of those buildings. For rating purposes,
the currently effective community
number is shown in the table below and
must be used for all new policies and
renewals.
SUMMARY:
These flood hazard
determinations will be finalized on the
dates listed in the table below and
revise the FIRM panels and FIS report
in effect prior to this determination for
the listed communities.
From the date of the second
publication of notification of these
changes in a newspaper of local
circulation, any person has 90 days in
DATES:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
which to request through the
community that the Deputy Associate
Administrator for Insurance and
Mitigation reconsider the changes. The
flood hazard determination information
may be changed during the 90-day
period.
ADDRESSES: The affected communities
are listed in the table below. Revised
flood hazard information for each
community is available for inspection at
both the online location and the
respective community map repository
address listed in the table below.
Additionally, the current effective FIRM
and FIS report for each community are
accessible online through the FEMA
Map Service Center at https://
msc.fema.gov for comparison.
Submit comments and/or appeals to
the Chief Executive Officer of the
community as listed in the table below.
FOR FURTHER INFORMATION CONTACT: Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Map Information eXchange
(FMIX) online at https://
www.floodmaps.fema.gov/fhm/fmx_
main.html.
SUPPLEMENTARY INFORMATION: The
specific flood hazard determinations are
not described for each community in
this notice. However, the online
location and local community map
repository address where the flood
hazard determination information is
available for inspection is provided.
Any request for reconsideration of
flood hazard determinations must be
submitted to the Chief Executive Officer
of the community as listed in the table
below.
The modifications are made pursuant
to section 201 of the Flood Disaster
Protection Act of 1973, 42 U.S.C. 4105,
and are in accordance with the National
Flood Insurance Act of 1968, 42 U.S.C.
4001 et seq., and with 44 CFR part 65.
The FIRM and FIS report are the basis
of the floodplain management measures
that the community is required either to
adopt or to show evidence of having in
effect in order to qualify or remain
qualified for participation in the
National Flood Insurance Program
(NFIP).
These flood hazard determinations,
together with the floodplain
management criteria required by 44 CFR
60.3, are the minimum that are required.
They should not be construed to mean
that the community must change any
existing ordinances that are more
stringent in their floodplain
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 84, Number 159 (Friday, August 16, 2019)]
[Notices]
[Pages 41993-41994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke,
Interagency Pain Research Coordinating Committee Call for Committee
Membership Nominations
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) (Department)
has created the Interagency Pain Research Coordinating Committee
(IPRCC) and is seeking nominations for this committee.
DATES: Nominations are due by COB September 23, 2019.
ADDRESSES: Nominations must be submitted through the webform on the
IPRCC website: https://iprcc.nih.gov/About/Membership-Agency-Representation/Nomination-Form.
FOR FURTHER INFORMATION CONTACT: Linda Porter, [email protected] or
301-451-4460.
[[Page 41994]]
SUPPLEMENTARY INFORMATION: As specified in Public Law 111-148
(``Patient Protection and Affordable Care Act'') the Committee will:
(A) Develop a summary of advances in pain care research supported
or conducted by the Federal agencies relevant to the diagnosis,
prevention, and treatment of pain and diseases and disorders associated
with pain;
(B) identify critical gaps in basic and clinical research on the
symptoms and causes of pain;
(C) make recommendations to ensure that the activities of the
National Institutes of Health and other Federal agencies are free of
unnecessary duplication of effort;
(D) make recommendations on how best to disseminate information on
pain care; and (e) make recommendations on how to expand partnerships
between public entities and private entities to expand collaborative,
cross-cutting research.
Membership on the committee will include six (6) non-Federal
members from among scientists, physicians, and other health
professionals and six (6) non-Federal members of the general public who
are representatives of leading research, advocacy, and service
organizations for individuals with pain-related conditions. Members
will serve overlapping three year terms. It is anticipated that the
committee will meet at least once a year.
The Department strives to ensure that the membership of HHS Federal
advisory committees is fairly balanced in terms of points of view
represented and the committee's function. Every effort is made to
ensure that the views of diverse ethnic and racial groups and people
with disabilities are represented on HHS Federal advisory committees,
and the Department therefore, encourages nominations of qualified
candidates from these groups. The Department also encourages geographic
diversity in the composition of the Committee. Appointment to this
Committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
The Department is soliciting nominations for 1 non-federal member
from among scientists, physicians, and other health professionals and
for 3 non-federal members of the general public who represent a leading
research, advocacy, or service organization for people with pain-
related conditions. These candidates will be considered to fill
positions opened through completion of current member terms.
Nominations are due by COB September 23, 2019, using the IPRCC
nomination webform: https://iprcc.nih.gov/About/Membership-Agency-Representation/Nomination-Form.
Dated: August 9, 2019.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke,
National Institutes of Health.
[FR Doc. 2019-17631 Filed 8-15-19; 8:45 am]
BILLING CODE 4140-01-P
